news aktuell GmbH

Materna IPS GmbH: Denver International Airport (DEN) opens the United States’ largest Self-Bag Drop (SBD) installation in cooperation with Materna IPS, United Airlines, and Southwest Airlines

Del

Denver International Airport (DEN) has successfully completed Phase 1 of its Great Hall Project. The newly renovated Level 6 has received rave reviews from passengers and airline staff ahead of the travel season specifically praising the user friendliness of the 86 new self-bag drop (SBD) systems developed by Materna IPS.

With over 73 million passengers expected to travel through DEN in 2022, the opening of the 86 self-bag drop systems perfectly aligns with the airport’s extensive technological redevelopment project; and is designed to provide passengers with the best check-in experience, including the ability to check-in over-sized luggage, like skis and snowboards. The unique hybrid self-bag drops are also equipped with counters and can be operated by the airline staff, when needed. This gives the airport the increased flexibility to meet the growth demand. Materna IPS developed the self-service systems according to the exact requirements of the airport with various partners and equipped them with state-of-the-art technology.

This project is the largest and most extensive hybrid self-bag drop (SBD) installation in the United States. The systems went live with Southwest Airlines early in November 2021 followed by United Airlines a week later. Within the first two weeks, over 35,000 bags have been processed with the newly integrated automatic baggage handling system. The Materna IPS systems were able to decrease the average passenger transaction time at DEN by nearly 50% during this period.

In addition to the hardware solution, Southwest Airlines will be using the Materna IPS SBD Application to operate the new automated baggage handling process. Materna IPS will also be responsible for hosting the self-bag drop system within the AWS Cloud where the availability and functionality of the SBD units are constantly monitored.

With the outstanding successful implementation of this major project at Denver International Airport, Materna IPS continues to strengthen its leading position in the American market and is expanding its international growth. Gary McDonald, president of Materna IPS USA, reiterates, "Everyone involved is absolutely honored to be part of this incredible, groundbreaking and innovative project that is revolutionizing passenger handling in the U.S. at one of the busiest airports in the world."

About Materna IPS USA Corp.

Materna IPS USA Corp. based in Orlando, Florida, as one of the most renowned suppliers for airports and airlines around the world, delivers solutions for automated passenger handling at airports. The company’s range of products and services is comprised of hardware and software implementations as well as service and maintenance. Materna IPS USA is part of Materna IPS GmbH - a 100% subsidiary of the Materna Group - with its headquarters in Germany. The international branches in the USA, Canada, India and the United Kingdom enable Materna IPS to support their customers individually and to react quickly and professionally to market requirements. The Materna Group currently employs more than 2,600 people around the world and generated sales of over a third of a $billion in 2020

More information:
Gary McDonald
President, Americas
Materna IPS USA
5323 Millenia Lakes Blvd., Suite 300
Orlando, Florida, USA
Phone: +1 619-724-9280
Email: gary.mcdonald@materna-ips.com

Press contact:
Jana Eull
Head of Marketing
Materna IPS GmbH
Vosskuhle 37, 44141 Dortmund
Germany
Phone: +49(231)5599-8691
Email: jana.eull@materna-ips.com

Bilder

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din epostadresse under for å få de nyeste sakene fra news aktuell GmbH på epost fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Grünenthal starts Phase III trials for resiniferatoxin in osteoarthritis-related pain18.8.2022 13:25:55 CEST | Pressemelding

Global Phase III programme to enable marketing authorisation in the EU, the US and Japan for an innovativenon-opioid investigational medicine. The programme will be conducted across approx. 200 study sites and include more than 1800 patients suffering from pain associated with osteoarthritis. Globally, more than 300 million patients suffer from osteoarthritis[1]. The global osteoarthritis market is expected to grow to approximately $11.0 billion in 2025[2]. Aachen, Germany – 18 August 2022 –Grünenthal announced today that the company has enrolled the first patient in its global clinical Phase III programme for resiniferatoxin (RTX). RTX is a highly potent Transient Receptor Potential Vanilloid 1 (TRPV1) agonist, with a well-validated mechanism of action. The discovery of TRPV1 was awarded the Nobel Prize of Physiology or Medicine in 2021. If approved, resiniferatoxin may provide patients with long-lasting pain relief with a favourable safety profile. Grünenthal’s Phase III programme wi

Animals' Angels: An ordeal that ends on a plate in a tourist resort: Live transports of calves to the Canary Islands10.8.2022 08:39:34 CEST | Press release

Every week, cattle are shipped to the Canary Islands under unacceptable conditions. These transports are extremely long. The animals stand on the truck for even more than 100 hours non-stop. Now, in summer, sweltering heat must be added as well as poor water supply, no or too little food, bedding of excrements and urine, lack of space, and an acrid ammonia smell. Once on the islands, the animals, only a few months old, await death in the slaughterhouse. A trade that is enhanced by subsidies and slaughter premiums.

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million4.8.2022 09:00:00 CEST | Pressemelding

(Aachen, Germany) Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal’s investigational medicine Resiniferatoxin (“RTX”). Shionogi obtained the exclusive rights to commercialise Grünenthal’s asset in Japan for pain associated with osteoarthritis of the knee. RTX is currently in Phase III of clinical development for the treatment of patients with moderate to severe pain associated with knee osteoarthritis. Osteoarthritis, a progressive and often painful joint disease, is an indication with high unmet medical need. If approved, RTX could become a well-tolerated, non-opioid therapy option for patients, providing long-lasting pain relief and functional improvement of the affected knee joints. Under the terms of the agreement, Shionogi will obtain the exclusive commercialisation rights for RTX in Japan for a total consideration of up to $ 525 million plus additional sales based payments. Thereof, Shionogi will pay $ 75 million upon signat

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom